Management of Reactive Treponemal Test with Negative RPR

Diagnostic Confirmation

Confirm a reactive treponemal screening result by performing a second treponemal assay (e.g., TP‑PA, FTA‑ABS, or MHA‑TP) to distinguish true Treponema pallidum exposure from a false‑positive screen. CDC recommendation. 1
If the second treponemal test is reactive, the presence of T. pallidum antibodies is confirmed and further clinical evaluation is required. CDC recommendation. 2

Reactive treponemal tests typically remain positive for life after adequate therapy. CDC recommendation. 1
A non‑reactive RPR following adequate treatment is expected and indicates successful cure. CDC recommendation. 2

For patients with confirmed treponemal reactivity and a negative RPR who have no documented prior treatment (late latent syphilis or syphilis of unknown duration), administer benzathine penicillin G 2.4 million units intramuscularly weekly for three weeks (total 7.2 million units). CDC recommendation. 5
For patients with recent exposure (<12 months) and no prior treatment (early latent syphilis), a single dose of benzathine penicillin G 2.4 million units intramuscularly is sufficient. Clinical guideline (source limited to Praxis). 3

Perform lumbar puncture before treatment when any neurologic signs or symptoms are present (e.g., cranial nerve deficits, meningitis, stroke, altered mental status, loss of vibration sense). CDC recommendation. 5
Perform lumbar puncture when ocular signs or symptoms are present; ocular syphilis occurs with a negative RPR in approximately 22 % of cases. CDC recommendation. 5
Perform lumbar puncture in the setting of HIV co‑infection with late latent or unknown‑duration syphilis, even in the absence of symptoms. CDC recommendations (1990s). [5][6]
Conduct CSF examination if, during follow‑up, the quantitative RPR becomes reactive or titers increase by ≥4‑fold. CDC recommendation. 5

All individuals with confirmed syphilis should be screened for HIV infection. Clinical guideline (source limited to Praxis). 3

HIV‑negative patients treated for late latent syphilis: repeat quantitative RPR at 6, 12, and 24 months after therapy; the RPR is expected to remain non‑reactive or low‑titer. CDC recommendation. 5
HIV‑positive patients: repeat quantitative RPR at 3, 6, 9, 12, 18, and 24 months after therapy; maintain a lower threshold for CSF examination if any serologic or clinical concerns arise. CDC recommendations (1990s). [5][6]